Submitted by dcc on Mon, 2021-06-07 13:49 Study Title: A Randomized Phase 3 trial of Nivolumab(NSC# 748726 IND# 125462) in Combination with Chemo-immunotherapy for the Treatment of Newly Diagnosed Primary Mediastinal B-cell LymphomaCIRB: Pediatric CIRBLead Group: COGStatus: ActiveReview Status: Available to Open
